Cleveland Clinic Pulmonologist Takes Helm at Pulmonary Fibrosis Foundation
The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
The Pulmonary Fibrosis Foundation announced Franck Rahaghi, MD, MHS, FCCP, as its incoming president, CEO, and chief medical officer, effective Sept 15.
Read MoreThe ATS and Sunovion released results of a survey of pulmonologists on their knowledge, attitudes, and practices related to COPD management and the use of hand-held small volume nebulizers.
Read MoreSeveral new pharmaceuticals are being developed for the treatment of COPD and asthma. Respiratory therapists need to be aware of these drugs to continue offering the best patient care.
Read MorePulmonary drug delivery will continue to evolve, and respiratory care practitioners are on the forefront to assist and potentially administer future pharmacotherapeutic agents.
Read MoreJason B. Karp, MD, named one of New York magazine’s 2006 “Best Doctors in New York,” offers his insights on what makes a successful pulmonologist.
Read MoreRT’s 2006 Respiratory Therapy Salary Survey finds salaries increasing for respiratory care practitioners but still lagging behind other allied health professions.
Read MoreAn aging workforce and higher compensation are but two of the significant changes noted over the past year, according to RT’s 2005 Respiratory Therapy Salary Survey.
Read MoreSluggish compensations and shifting demographics are among findings in RT’s 2004 Respiratory Therapy Salary Survey.
Read MoreRespiratory therapists share compensatory and work environment information reflecting today’s tight respiratory market in this inaugural RT magazine survey.
Read More